View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
April 3, 2020

Cassia Networks and VivaLNK partner to help China fight Covid-19

Cassia Networks and VivaLNK have partnered to help China fight the coronavirus (Covid-19) by lending their technologies to the Shanghai Public Health Clinical Center (SPHCC).


Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Follow the latest updates of the outbreak on our timeline


Cassia Networks and VivaLNK have partnered to help China fight the coronavirus (Covid-19) by lending their technologies to the Shanghai Public Health Clinical Center (SPHCC).

As part of the partnership, SPHCC is currently using Cassia’s gateways and VivaLNK’s medical wearable sensors.

The spread of the pandemic within the clinical centre, especially cross-infection from patient-to-patient and patient-to-caregiver, remains a key problem.

The integration of Cassia’s gateways and IoT Access Controller with VivaLNK’s body temperature sensors is aimed at solving the issue by reducing the contact between patient and medical staff and the contact amongst the patients.

Cassia Networks CEO Felix Zhao said: “Cassia is excited to be working with VivaLNK to help fight the spread of infectious diseases such as Covid-19, as well as helping save lives.

“With the combination of VivaLNK’s continuous health monitoring solutions, Cassia’s Bluetooth gateways and IoT Access Controller, we can better equip clinical centres and medical staff worldwide with the critical tools they need to address this and future pandemics.”

VivaLNK’s body temperature sensors supply constant, real-time monitoring of any changes in body temperature.

Cassia’s gateways gather the data and wirelessly transmit it to a nurse’s station for continuous monitoring through IoT Access Controller.

It enables medical staff to provide a holistic view of their vitals in real-time.

40 Bluetooth Low Energy devices can be paired and connected simultaneously with Cassia’s gateway.

VivaLNK CEO Jiang Li said: “The concept of remote patient monitoring using wireless medical wearables can extend into a clinical environment where there is a need to minimise patient contact and for a more flexible deployment model.

“The combination of VivaLNK sensors and Cassia’s gateways enables medical centres to rapidly deploy patient monitoring solutions not only in China but worldwide.”

Deployment of additional systems in other medical centres is expected to take place in the coming days.

Meanwhile, both companies are also working to enable future integration, using VivaLNK’s Multi-Vital ECG Sensor and Cassia’s gateways.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network